N. Gattermann Et Al. , "Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study," Leukemia Research , vol.34, no.9, pp.1143-1150, 2010
Gattermann, N. Et Al. 2010. Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study. Leukemia Research , vol.34, no.9 , 1143-1150.
Gattermann, N., Finelli, C., Della Porta, M., Fenaux, P., Ganser, A., Guerci-Bresler, A., ... Schmid, M.(2010). Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study. Leukemia Research , vol.34, no.9, 1143-1150.
Gattermann, Norbert Et Al. "Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study," Leukemia Research , vol.34, no.9, 1143-1150, 2010
Gattermann, Norbert Et Al. "Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study." Leukemia Research , vol.34, no.9, pp.1143-1150, 2010
Gattermann, N. Et Al. (2010) . "Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study." Leukemia Research , vol.34, no.9, pp.1143-1150.
@article{article, author={Norbert Gattermann Et Al. }, title={Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study}, journal={Leukemia Research}, year=2010, pages={1143-1150} }